Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Response of Candida albicans towards a novel antifungal benzimidazole derivative


ABSTRACT: Fungal infections are a serious health problem in the clinic especially in the immunocompromised patient. Disease ranges from widespread superficial vulvovaginal infections to life-threatening systemic candidiasis. Especially for systemic mycoses only a limited arsenal of antimycotica are available, including azoles, polyenes, echinocandines and amphothericin B. Due to emerging resistance to standard therapy and significant side effects for some antimycotica there is a medical need for new antifungals in the clinic and general practice. In order to expand the arsenal of compounds with antifungal activities we screened compound libraries, including combinatorial libraries as well as more than 30 000 pure compounds derived from organic synthesis for antimycotic activity. In total more than 100 000 compounds were screened using an innovative AS (activity-selectivity) assay analyzing both the antifungal activity and the compatability with human cells at the same time. One promising hit, a Benzimidazol-2-yl-alkylamine derivative, was developed in a series of lead compounds showing potent antifungal activity. ((1S)-1-[1-(3-chlorobenzyl)-1H-benzimidazol-2-yl]-2-methylpropyl-amine) (EMC120B12) showed the highest antifungal activity and best compatability with human cells in several cell culture models and against a number of different yeasts and clinical isolates. Transcriptional profiling indicates that the newly discovered compound is a potential inhibitor of the ergosterol-pathway. In total, three biological replicates were performed. All experiments were performed as dye swaps. Thus, in total six arrays have been hybridzed. Hybridization experiments included an untreated reference sample and a sample of cells treated with ((1S)-1-[1-(3-chlorobenzyl)-1H-benzimidazol-2-yl]-2-methylpropyl-amine) (EMC120B12). The array included one technical replicate of each probe.

ORGANISM(S): Candida albicans

SUBMITTER: Karin Lemuth 

PROVIDER: E-GEOD-21622 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Adaptation, adhesion and invasion during interaction of Candida albicans with the host--focus on the function of cell wall proteins.

Hiller Ekkehard E   Zavrel Martin M   Hauser Nicole N   Sohn Kai K   Burger-Kentischer Anke A   Lemuth Karin K   Rupp Steffen S  

International journal of medical microbiology : IJMM 20110514 5


Infectious diseases have long been regarded as losing their threat to mankind. However, in the recent decades infectious diseases have been regaining grounds and are back in the focus of research. This is also due to the fact that medical progress has enabled us to treat and cure a much higher fraction of severe diseases or trauma, resulting in a significant proportion of temporarily or constantly immune-suppressed patients. Infectious diseases result from the interplay between pathogenic microo  ...[more]

Publication: 1/2

Similar Datasets

2015-06-30 | E-GEOD-64976 | biostudies-arrayexpress
2013-03-25 | E-GEOD-28212 | biostudies-arrayexpress
2011-07-15 | GSE21622 | GEO
2011-07-02 | E-GEOD-30353 | biostudies-arrayexpress
2012-03-01 | E-GEOD-35872 | biostudies-arrayexpress
2011-11-01 | E-GEOD-29874 | biostudies-arrayexpress
2009-05-09 | E-GEOD-15972 | biostudies-arrayexpress
2009-12-01 | E-MEXP-2266 | biostudies-arrayexpress
2009-05-04 | E-GEOD-15881 | biostudies-arrayexpress
2009-05-09 | E-GEOD-15973 | biostudies-arrayexpress